New patent expiration for Gilead Sciences drug ATRIPLA
Annual Drug Patent Expirations for ATRIPLA Atripla is a drug marketed by Gilead Sciences and is included in one NDA. […]
New patent expiration for Gilead Sciences drug ATRIPLA Read Post »
Patent Expiration
New patent expiration for Gilead Sciences drug COMPLERA
Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug COMPLERA Read Post »
New patent expiration for Gilead Sciences drug STRIBILD
Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug STRIBILD Read Post »
New patent expiration for Gilead drug TRUVADA
Annual Drug Patent Expirations for TRUVADA Truvada is a drug marketed by Gilead and is included in one NDA. It
New patent expiration for Sun Pharm drug WINLEVI
Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA.
New patent expiration for Sun Pharm drug WINLEVI Read Post »
New patent expiration for Mylan Speciality drug TOBI PODHALER
Annual Drug Patent Expirations for TOBI+PODHALER Tobi Podhaler is a drug marketed by Mylan Speciality Lp and is included in
New patent expiration for Mylan Speciality drug TOBI PODHALER Read Post »
Drug Patent Expirations for the Week of January 7, 2024
TOBI PODHALER (tobramycin) Mylan speciality lp Patent: 7,516,741 Expiration: Jan 11, 2024 See More … For more information on how
Drug Patent Expirations for the Week of January 7, 2024 Read Post »
New patent expiration for Btcp Pharma drug LAZANDA
Annual Drug Patent Expirations for LAZANDA Lazanda is a drug marketed by Btcp Pharma and is included in one NDA.
New patent expiration for Btcp Pharma drug LAZANDA Read Post »
New patent expiration for Novartis drug TASIGNA
Annual Drug Patent Expirations for TASIGNA Tasigna is a drug marketed by Novartis and is included in one NDA. It
